Hikma Pharmaceuticals Share News (HIK)

Hikma subsidiary receives FDA approval for Temozolomide capsules

(ShareCast News) - Hikma Pharmaceuticals' fully-owned subsidiary West-Ward Pharmaceuticals has received approval from the US Food and Drug Administration for its abbreviated new drug application for Temozolomide capsules. Temozolomide is a chemotherapy agent used to treat a severe form of brain canc

DIRECTOR DEALINGS: Hikma Non-Executive Ups Interest

BROKER RATINGS SUMMARY: JPMorgan Starts Countryside At Overweight

DIRECTOR DEALINGS: Hikma Pharmaceuticals Director Buys 2,500 Shares

BROKER RATINGS SUMMARY: Goldman Sachs Starts Ascential With Buy Rating

LONDON MARKET CLOSE: UK Budget Lifts Stocks As Focus Turns To Fed

Wednesday broker round-up

(ShareCast News) - Hikma Pharmaceuticals: Panmure Gordon upgrades to buy with a target price of 2120p. Greggs: Berenberg upgrades to hold, 1020p target. Firestone Diamonds: Panmure Gordon reiterates buy with a target price of 27p and Finncap stays at buy with a target price of 51p. Cairn Energy: C

LONDON MARKET MIDDAY: Stocks Firm Before UK Budget And US Fed Decision

WINNERS & LOSERS SUMMARY: Forbidden Technologies Up On Microsoft Deal

LONDON MARKET OPEN: Commodity Stocks Take Back Losses But Hikma Falls

London pre-open: Stocks seen a little higher ahead of Budget, FOMC

(ShareCast News) - London stocks are set to open a little higher on Wednesday as the focus shifts to Chancellor George Osborne's Budget and the rate decision from the Federal Reserve. The FTSE 100 is seen starting 22 points firmer than Tuesday's close at 6,162. The Budget statement is at 1230 GM

Hikma Pharmaceuticals Guides For Growth In 2016 As Profit Falls

Currency headwinds push Hikma Pharmaceuticals profits down

(ShareCast News) - Drug group Hikma Pharmaceuticals reported revenue of $1.44bn (£1.02bn) in its final results for 2015 on Wednesday, down 3% on what was an exceptionally strong 2014. Its gross margin remained in line with 2014, at 56.8%, reflecting Hikma's cost control efforts across the business.

Earnings, Trading Statements Calendar - Week Ahead

Sports Direct to drop out of FTSE 100 in reshuffle

* WM Morrison, Paddy Power and Betfair to join FTSE 100 * Informa and Mediclinic to also join FTSE 100 * Sports Direct, Aberdeen AM, Smiths, Hikma drop out * Changes will take effect on March 21 By Sudip Kar-Gupta LONDON, March 2 (Reuters) - Sports Direct and Aberdee